Work to lower prescription drug costs for Americans with employer-based or individually purchased health insurance.

by helping to lower drug costs for Americans who get health insurance through their job or purchase it on their own.

Cortez Masto and colleagues made a future-oriented commitment to reduce prescription drug costs for people with employer-provided or individual market insurance.

Cortez Masto, Wyden, Colleagues Announce Plans for Expanding Future Drug Price Negotiations, Denounce Trump’s Failure to Lower Cost of Prescription Drugs
primary · press_release · model gpt-4.1

On February 4, 2026, Cortez Masto said Democrats had a plan to lower prescription drug costs further, including helping lower drug costs for Americans who get health insurance through their job or purchase it on their own.

This is a fresh, official statement that the senator is still actively pursuing the claim, but it describes a plan rather than a completed policy change.

unresolved same_term A for effort

Cortez Masto, Wyden, Colleagues Announce Plans for Expanding Future Drug Price Negotiations, Denounce Trump’s Failure to Lower Cost of Prescription Drugs
primary · model gpt-5.4-mini · confidence 95%

Congress.gov shows Cortez Masto introduced S.1186, which would extend Medicare-style drug rebate rules to prescription drugs available under private health insurance; the bill remained at the introduced stage on the site snapshot.

This is concrete legislative action aligned with the promise, but the bill was only introduced and not enacted, so it does not prove delivery.

partial same_term A for effort

S.1186 - 119th Congress (2025-2026): Lower Drug Costs for Families Act | Congress.gov | Library of Congress
secondary · model gpt-5.4-mini · confidence 93%

Cortez Masto's Senate office said she and colleagues announced a Democratic plan to lower prescription drug costs, including for Americans who get insurance through work or buy coverage themselves. The release says Democrats have a plan and will keep fighting to lower health care costs.

Official statement shows continued same-term advocacy directly matching employer-based and individually purchased insurance, but it describes a plan rather than an enacted policy.

unresolved same_term A for effort

Cortez Masto, Wyden, Colleagues Announce Plans for Expanding Future Drug Price Negotiations, Denounce Trump’s Failure to Lower Cost of Prescription Drugs
primary · model gpt-5.5 · confidence 95%

Congress.gov lists S.1186, the Lower Drug Costs for Families Act, sponsored by Sen. Catherine Cortez Masto and introduced March 27, 2025. The latest action is that it was read twice and referred to the Senate Finance Committee, and the tracker status is Introduced.

Cortez Masto introduced a bill aligned with the promise, but Congress.gov shows it had not advanced beyond introduction, so it did not deliver the promised outcome.

partial same_term A for effort

S.1186 - 119th Congress (2025-2026): Lower Drug Costs for Families Act | Congress.gov | Library of Congress
secondary · model gpt-5.5 · confidence 97%

The introduced text says the bill would amend title XVIII of the Social Security Act to apply prescription drug inflation rebates to drugs furnished in the commercial market. It identifies Cortez Masto as introducing the bill with other senators.

The bill text confirms the legislative effort was aimed at commercial/private coverage, the target population in the promise. Because it remained introduced, it is evidence of effort, not fulfillment.

partial same_term A for effort

Text - S.1186 - Lower Drug Costs for Families Act, 119th Congress (2025-2026)
secondary · model gpt-5.5 · confidence 96%

Congress.gov lists related bill H.R.2554, also titled the Lower Drug Costs for Families Act, with latest action on April 1, 2025: referral to the House Energy and Commerce and Ways and Means committees.

The House companion was also only referred to committees, reinforcing that the commercial-market drug-cost proposal had not become law by the assessment date.

never same_term A for effort

Related Bills - S.1186 - Lower Drug Costs for Families Act, 119th Congress (2025-2026)
secondary · model gpt-5.5 · confidence 90%

Congress.gov shows H.R.5376 became Public Law 117-169 on August 16, 2022. Its prescription drug pricing reforms require CMS negotiations and inflation rebates for drugs covered under Medicare prescription drug benefits or Medicare medical services, and include Medicare Part D out-of-pocket and insulin cost provisions.

The major enacted federal drug-pricing law lowered Medicare drug costs, but Congress.gov's summary limits the relevant negotiation, rebate, and out-of-pocket provisions to Medicare rather than employer-based or individually purchased private coverage.

never same_term

H.R.5376 - Inflation Reduction Act of 2022
secondary · model gpt-5.5 · confidence 93%

The Senate roll call for H.R.5376 shows the bill passed 51-50 on August 7, 2022, with the Vice President voting yea. The alphabetical vote listing records Cortez Masto (D-NV) voting yea.

Cortez Masto supported the enacted Inflation Reduction Act, but that law's prescription drug provisions were Medicare-focused, so this is effort on drug costs rather than delivery for private employer-based or individual insurance.

partial same_term A for effort

U.S. Senate Roll Call Vote 117th Congress, 2nd Session, Vote 325
secondary · model gpt-5.5 · confidence 92%

Axios reported that the Senate parliamentarian struck provisions that would have required rebates when prices for drugs sold to private insurers rose faster than inflation, while Medicare negotiation and senior out-of-pocket provisions remained in the bill.

This explains why the enacted 2022 drug-pricing package did not extend the inflation-rebate price break to private insurance, supporting a failure finding for the employer-based and individually purchased insurance portion of the promise.

never same_term A for effort

Private insurers won't get drug price break, clause struck from Senate bill
secondary · model gpt-5.5 · confidence 84%